Hairy root (HR) cultures derived from Agrobacterium rhizogenes (A. rhizogenes) transformation of plant tissues are an advantageous biotechnological manufacturing platform due to the accumulation of recombinant proteins in an otherwise largely protein free culture medium. In this context, HRs descending from transgenic Nicotiana tabacum (N. tabacum) plants were successfully used for the production of several functional mAbs with plant-type glycans. Here, we expressed the tumour-targeting mAb H10 in HRs obtained either by infecting a transgenic N. tabacum line expressing H10 with A. rhizogenes or a glyco-engineered N. benthamiana line (?XTFT) with recombinant A. rhizogenes carrying mAb H10 heavy and light chain cDNAs. Selected HR clones derived from both plants accumulated mAb H10 in the culture medium with similar yields (2-3 mg/L). N-glycosylation profiles of antibodies purified from HR supernatant revealed the presence of plant-typical complex structures for N. tabacum-derived mAbH10 and of GnGn structures lacking xylose and fucose for the ?XTFT-derived counterpart. Both antibody glyco-formats exhibited comparable antigen binding activities. Collectively, these data demonstrate that the co-infection of ?XTFT N. benthamiana with recombinant A. rhizogenes is an efficient procedure for the generation of stable HR cultures expressing the tumour-targeting mAb H10 with a human-compatible glycosylation profile, thus representing an important step towards the exploitation of root cultures for the production of 'next generation' human therapeutic antibodies.
Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures.
Scaloni A;Salzano AM;
2016
Abstract
Hairy root (HR) cultures derived from Agrobacterium rhizogenes (A. rhizogenes) transformation of plant tissues are an advantageous biotechnological manufacturing platform due to the accumulation of recombinant proteins in an otherwise largely protein free culture medium. In this context, HRs descending from transgenic Nicotiana tabacum (N. tabacum) plants were successfully used for the production of several functional mAbs with plant-type glycans. Here, we expressed the tumour-targeting mAb H10 in HRs obtained either by infecting a transgenic N. tabacum line expressing H10 with A. rhizogenes or a glyco-engineered N. benthamiana line (?XTFT) with recombinant A. rhizogenes carrying mAb H10 heavy and light chain cDNAs. Selected HR clones derived from both plants accumulated mAb H10 in the culture medium with similar yields (2-3 mg/L). N-glycosylation profiles of antibodies purified from HR supernatant revealed the presence of plant-typical complex structures for N. tabacum-derived mAbH10 and of GnGn structures lacking xylose and fucose for the ?XTFT-derived counterpart. Both antibody glyco-formats exhibited comparable antigen binding activities. Collectively, these data demonstrate that the co-infection of ?XTFT N. benthamiana with recombinant A. rhizogenes is an efficient procedure for the generation of stable HR cultures expressing the tumour-targeting mAb H10 with a human-compatible glycosylation profile, thus representing an important step towards the exploitation of root cultures for the production of 'next generation' human therapeutic antibodies.File | Dimensione | Formato | |
---|---|---|---|
prod_355882-doc_119345.pdf
solo utenti autorizzati
Descrizione: Production of a tumor-targeting antibody with a human- compatible glycosylation profile in N. benthamiana hairy root cultures
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
2.14 MB
Formato
Adobe PDF
|
2.14 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
prod_355882-doc_185699.pdf
accesso aperto
Descrizione: Preprint: Production of a tumor-targeting antibody with a human- compatible glycosylation profile in N. benthamiana hairy root cultures
Tipologia:
Versione Editoriale (PDF)
Licenza:
Nessuna licenza dichiarata (non attribuibile a prodotti successivi al 2023)
Dimensione
1.8 MB
Formato
Adobe PDF
|
1.8 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.